Rajender Syal
Obstetrics & Gynecology · Shenandoah, TXNPI 1316095797
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,124 of the $10,976 with a category attached, or 74.0%. It is spread thinly across 58 manufacturers, the largest accounting for just 21.3%. Reporting peaked in 2019 at $3,377 and has fallen 67.7% since, to $1,090 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 432 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- Intuitive Surgical$1K
- AbbVie$957
- Biogen$624
- Mayne Pharma Commercial LLC$577
- Daiichi Sankyo Inc.$395
- plus $5K from 52 others
What the payments were for
- Travel & lodging$2,40922%
- Food & beverage$8,12474%
- Education$3974%
- Gifts$460%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,875
- Da Vinci Surgical System$1,027
- Orilissa$225
- EXPAREL$223
- Desara$156
- MYRBETRIQ$117
- BIJUVA$112
- Uterine Manipulators & Injectors$112
- aveta$107
- V-LOC 180$100
How this compares
$10,976 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 58 | $7,068 |
| PremarinEstrogens, Conjugated | 11 | $5,973 |
| ProgesteroneProgesterone, Micronized | 104 | $3,596 |
| LyllanaEstradiol | 12 | $1,479 |
| Estradiol | 13 | $1,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $259 | $5,97311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Shenandoah
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.